Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
GILD holding history
Gilead Sciences, Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GILD overviewAll 13F holders of GILDFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,480−100.0% | Sold out | Holders |
| Q1 2026 | 1,480 | $206.3K | <0.1% | +1,480 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −10,099−100.0% | Sold out | Holders |
| Q4 2023 | 10,099 | $818.1K | 0.1% | −57−0.6% | Reduced | Holders |
| Q3 2023 | 10,156 | $761.1K | 0.1% | −826−7.5% | Reduced | Holders |
| Q2 2023 | 10,982 | $846.3K | 0.1% | −1,188−9.8% | Reduced | Holders |
| Q1 2023 | 12,170 | $1.01M | 0.1% | −552−4.3% | Reduced | Holders |
| Q4 2022 | 12,722 | $1.09M | 0.1% | +97+0.8% | Added | Holders |
| Q3 2022 | 12,625 | $779.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 12,625 | $780.0K | 0.1% | +857+7.3% | Added | Holders |
| Q1 2022 | 11,768 | $700.0K | 0.1% | −46,544−79.8% | Reduced | Holders |
| Q4 2021 | 58,312 | $4.23M | 0.3% | −82−0.1% | Reduced | Holders |
| Q3 2021 | 58,394 | $4.08M | 0.3% | −191−0.3% | Reduced | Holders |
| Q2 2021 | 58,585 | $4.03M | 0.3% | +1,343+2.3% | Added | Holders |
| Q1 2021 | 57,242 | $3.70M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.